insights_auto
Why is ANAB up 5.64%?
Dive Deeperchevron_right
ANAB:NASDAQ
AnaptysBio Inc
$49.24
arrow_upward
+5.64%(+2.63) 1D
$50.88
arrow_upward
+3.33% (+1.64)bedtimeAfter hours
Closed: Oct 19, 4:00:01 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ANAB...
Open
$47.33
High
$49.88
Low
$47.33
Mkt. cap
1.47B
Avg. vol.
568.76K
Volume
468.35K
52-wk high
$72.36
52-wk low
$20.18
Beta
0.45
Shares outstanding
29.90M
No. of employees
104
Open
$47.33
High
$49.88
Low
$47.33
Mkt. cap
1.47B
Avg. vol.
568.76K
Volume
468.35K
52-wk high
$72.36
52-wk low
$20.18
Beta
0.45
Shares outstanding
29.90M
No. of employees
104
News stories
From web sources and news partners
Simply Wall Street
·
11 minutes ago
AnaptysBio (ANAB) On Jemperli Approval Is The Royalty Story Still A Bargain
GuruFocus
·
9 hours ago
AnaptysBio (ANAB) Shares Rise After GSK's FDA Label Expansion fo
Seeking Alpha
·
10 hours ago
AnaptysBio gains as GSK granted FDA label expansion for Jemperli
About AnaptysBio Inc
CEO-
Employees104
Founded2005
HeadquartersSan Diego, California, United States
SectorBiotechnology
Websiteanaptysbio.com